A Forbes article shedding light on #CBD and its effects on the livers of mice. Dr Peter Grinspoon and Devitt-Lee wisely talk some sense around the lousy methods and insensible dosage used on mice to command sensational headlines. http://bit.ly/2XMP36W
The CED Foundation review of the topic: http://bit.ly/2jYOlFX
As it stands, there is no cure for Type 1 Diabetes Mellitus. But, some of us in the medical community are starting to wonder if cannabis could be a viable treatment option. Several studies already address this, with impressive findings, and now, A new mouse model study suggests that not only could CBD prevent Type 1 Diabetes, but it seems to also reduce symptoms after onset.
Now researchers must determine the long term effects of CBD treatment. Watch a video summary below:
View this review (yellow link) or download:
This paper is also stored here: http://bit.ly/2Y1paV5 inside the CED Foundation Archive
To explore related information, click the keywords below:
Title: CB1 receptor antagonism in capuchin monkeys alters social interaction and aversive memory extinction
A recent study has revealed that the dysregulation of the endocannabinoid system may play a role in autism spectrum disorders (ASD). Using non-human primates, researchers were able to mimic some of the social impairment seen in autism models by antagonizing cannabinoid 1 receptors with synthetic cannabinoids. Future research may continue to show links between ASD and the endocannabinoid system, suggesting that cannabinoids may be used to treat the social impairments characteristic in ASD.
This research highlights how the endocannabinoid system may provide novel targets for developing therapies for what have seemed, previously, to be treatment-resistant disorders. Autism is still not well-understood and has many false beliefs associated with it. By studying the possible role of the endocannabinoid systems in ASD, researchers may be able to shed light on the mechanism(s) underlining the disorders and develop targeted treatments that allow patients a degree of greater control over the symptoms.
View this review (yellow link) or download:
This paper is also stored here: http://bit.ly/2Ju4dds inside the CED Foundation Archive
To explore related information, click the keywords below:
A 2018 literature review summarizes the findings on cannabis and gut health. The endocannabinoid system plays a key role in gut motility, obesity, and inflammatory bowel disease (IBD). Targeting the endocannabinoid system with CBD oil or other cannabinoids seems to reduce colonic inflammation and relieve stress, at a microscopic level, inside the gastrointestinal tract. Watch our video adaptation of the effects of cannabis on IBD:
View this review (yellow link) or download:
This paper is also stored here: http://bit.ly/2IQCNy1 inside the CED Foundation Archive
To explore related information, click the keywords below:
According to multiple mouse-models, THC administered directly into cancerous tumors produces a reduction in tumor sizes.
View this review (yellow link) or download:
This paper is also stored here: http://bit.ly/2FfKagk inside the CED Foundation Archive
To explore related information, click the keywords below:
Euphorbia honey and garlic- Biological activity and burn wound recovery
A recent study has shown that a combination of euphorbia honey and garlic can help heal burn wounds. Euphorbia honey and garlic have antioxidant, microbial, and healing properties that have now been confirmed to be effective when treating wounds resulting from exposure to extreme heat. Combining natural ingredients has been common in traditional medicine for years, but now western medicine is beginning to look at more natural compounds to aid in recovery and treatment methods.
This paper is also stored here: http://bit.ly/2Fbqk5F inside the CED Foundation Archive
View this review (yellow link) or download:
To explore related information, click the keywords below:
CBD treatment in a mouse model for Dravet Syndrome effectively reduced seizures and autism-like behaviors
View this review (yellow link) or download:
This paper is also stored here: http://bit.ly/2WA1jXO inside the CED Foundation Archive
To explore related information, click keywords below:
In a study of 40 mice, scientists find that the CB2-selective agonist significantly reduced the severity of arthritis and markedly reduced bone erosion. These data clearly indicate that the CB2-selective agonist may be considered a novel treatment for rheumatoid arthritis.
